Ovid Therapeutics Inc. Files Form 4 for Ownership Changes
Ticker: OVID · Form: 4 · Filed: 2026-04-09T17:15:09-04:00
Sentiment: neutral
Topics: insider-transaction, ownership-change, form-4
Related Tickers: OVID
TL;DR
Ovid Therapeutics (OVID) insiders filed a Form 4 on 4/9/26 showing ownership changes from 4/7/26.
AI Summary
On April 9, 2026, Ovid Therapeutics Inc. filed a Form 4, reporting changes in beneficial ownership of securities. Stelios Papadopoulos, a reporting person, made transactions related to Ovid Therapeutics Inc. The filing details transactions that occurred on April 7, 2026.
Why It Matters
Form 4 filings are crucial for investors as they disclose changes in stock ownership by company insiders, providing insights into their confidence in the company's prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of insider stock transactions and does not inherently indicate significant risk.
Key Numbers
- 2026-04-09 — Filing Date (Date the Form 4 was filed with the SEC.)
- 2026-04-07 — Period of Report (Date of the reported stock transactions.)
Key Players & Entities
- Ovid Therapeutics Inc. (company) — Issuer
- Stelios Papadopoulos (person) — Reporting Person
- 0001636651 (company) — Ovid Therapeutics Inc. CIK
- 0001202098-26-000004 (document) — SEC Accession Number
FAQ
What type of filing is this?
This is a Form 4 - Statement of changes in beneficial ownership of securities.
Who is the issuer?
The issuer is Ovid Therapeutics Inc. (CIK: 0001636651).
When was the filing accepted by the SEC?
The filing was accepted on 2026-04-09 at 17:15:09.
Who is listed as a reporting person?
Stelios Papadopoulos is listed as a reporting person.
What is the period of report for the transactions?
The period of report for the transactions is 2026-04-07.
From the Filing
EDGAR Filing Documents for 0001202098-26-000004 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001202098-26-000004 Filing Date 2026-04-09 Accepted 2026-04-09 17:15:09 Documents 1 Period of Report 2026-04-07 Document Format Files Seq Description Document Type Size 1 form4-04092026_050404.html 4 1 form4-04092026_050404.xml 4 3822 Complete submission text file 0001202098-26-000004.txt 5237 Mailing Address C/O EXELIXIS, INC. 1851 HARBOR BAY PKWY ALAMEDA CA 94502 Business Address PAPADOPOULOS STELIOS ( Reporting ) CIK : 0001202098 (see all company filings) Type: 4 | Act: 34 | File No.: 001-38085 | Film No.: 26852529 Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381 Ovid Therapeutics Inc. ( Issuer ) CIK : 0001636651 (see all company filings) EIN. : 465270895 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)